Lercanidipine Reduces Matrix Metalloproteinase-9 Activity in Patients With Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lercanidipine Reduces Matrix Metalloproteinase-9 Activity in Patients With Hypertension

Published:2006-01 Issue:1 Volume:47 Page:117-122
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Martinez Marcio LL,Lopes Lívia F,Coelho Eduardo B,Nobre Fernando,Rocha João B. T,Gerlach Raquel F,Tanus-Santos Jose E

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference33 articles.

1. Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease.;Assmann;Arterioscler Thromb Vasc Biol,1999

2. Atherosclerotic vascular disease conference: Writing Group III: pathophysiology.;Faxon;Circulation,2004

3. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.;Galis;Circ Res,2002

4. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).;Tayebjee;Am J Hypertens,2004

5. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.;Tayebjee;Am J Hypertens,2004

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13

2. Lercanidipine alleviates doxorubicin-induced lung injury by regulating PERK/CHOP and Bax/Bcl 2/Cyt c pathways;Histochemistry and Cell Biology;2023-09-06

3. Cardiovascular benefits of air purifier in patients with stable coronary artery disease: A randomized single-blind crossover study;Frontiers in Public Health;2023-01-09

4. Apparent Mineralocorticoid Excess;Endocrinology;2023

5. Doksorubisin ile Oluşturulan Böbrek Hasarında Lerkanidipinin Antioksidan ve Antiapoptotik Etkilerinin Bcl-2/Bax/Sit c/Cas-3 Yolağı Üzerinden Araştırılması;SDÜ Tıp Fakültesi Dergisi;2022-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3